移植后的左心室缩:系统审查和元分析
Zhejia Tian1, Kai Bergmann1, Jessica Kaufeld1
1Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Transplantation direct
|May 21, 2024
概括
移植可以通过减少左心室缩 (LVH) 来提供心血管方面的好处. 改进的血压控制,而不是移植本身,似乎在末期病患者中推动了这种LVH回归.
科学领域:
- 腎病學和心臟病學.
- 在病中心血管健康.
- 脏替代疗法治疗结果
背景情况:
- 左心室缩 (LVH) 是最终阶段病 (ESRD) 患者心血管疾病的重要危险因素.
- 脏替代疗法,包括透析和脏移植 (KT),对LVH有不同的影响.
- 关于KT对LVH的影响的证据需要进一步探索.
研究的目的:
- 研究ESRD患者的移植 (KT) 和左心室缩 (LVH) 之间的关系.
- 分析左心室质量指数 (LVMI) 随着KT的变化.
- 为了确定影响LVMI转移后变化的因素.
主要方法:
- 在MEDLINE和Scopus数据库的系统文献搜索 (2023年10月).
- 包括评估LVMI变化的横截面和纵向研究.
- 使用随机效应模型和共变量分析的元回归进行元分析.
主要成果:
- 包括4122名参与者的46项研究;纵向数据显示,KT后的LVMI改善 (-0.44 g/m2).
- 血压,KT时的年轻年龄和受控的贫血与LVH回归有关.
- 在直接比较中,透析患者和移植接受者之间没有发现LVMI的显著差异.
结论:
- 移植可能通过LVH回归带来心血管益处.
- 改善血压控制是KT后LVH回归的一个关键驱动因素.
- 观察到的好处可能与伴随性疾病的管理有关,而不是仅仅与移植有关.
更多相关视频
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
3.5K
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
712
相关概念视频
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
